- Stage
- In committee
- Started in
- House
- Sponsors
- 19
- Latest action
- Sep 2, 2026
What it does
The INSULIN Act of 2026 aims to reduce insulin costs and improve patient protections by requiring group health plans and insurers to cover selected insulin products without applying deductibles and limiting cost-sharing to $35 per 30-day supply or 25% of the negotiated price (whichever is less) for plan years beginning on or after January 1, 2028. It prohibits prior authorization and medical management requirements for these products except when clinically justified, and extends similar coverage requirements to catastrophic health plans. The bill also mandates a GAO study on uninsured insulin users and establishes a federal grant program to create an insulin resource center and hotline to…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.